Clinical Trials List
2018-03-01 - 2021-03-31
Phase III
Terminated4
ICD-10F20.89
Other schizophrenia
ICD-10F20
Schizophrenia
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
- Cheng-Ta Li Division of Psychiatry
- Mu-Hong Chen Division of Psychiatry
- W. C. LIN Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 徐監棋 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Completed
Taiwan National PI
The Actual Total Number of Participants Enrolled
7 Completed
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
765 participants
